Decapeptyl (triptorelin): Reviews and patient testimonials
Back to the list of medications
Medication indications
Decapeptyl SR 11.25mg
Treatment of patients with locally advanced, non-metastatic prostate cancer, as an alternative to surgical castration. Treatment of metastatic prostate cancer.As adjuvant treatment to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.As neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.As adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression.Treatment of endometriosis.Treatment of precocious puberty (onset before 8 years in girls and 10 years in boys).Decapeptyl SR 11.25mg (triptorelin pamoate)
Treatment of patients with locally advanced, non-metastatic prostate cancer, as an alternative to surgical castration.
Treatment of metastatic prostate cancer.
As adjuvant treatment to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
As neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
As adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression.
Treatment of endometriosis.
Treatment of precocious puberty (onset before 8 years in girls and 10 years in boys).
Decapeptyl SR 22.5mg
Treatment of patients with locally advanced, non-metastatic prostate cancer, as an alternative to surgical castration.
Treatment of metastatic prostate cancer.
As adjuvant treatment to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
As neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
As adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression.
Treatment of central precocious puberty (CPP) in children 2 years and older with an onset of CPP before 8 years in girls and 10 years in boys).
Decapeptyl SR 3mg
Treatment of patients with locally advanced, non-metastatic prostate cancer, as an alternative to surgical castration.
Treatment of metastatic prostate cancer.
As adjuvant treatment to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
As neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
As adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression.
Treatment of endometriosis.
Treatment of uterine fibroids prior to surgery or when surgery is not appropriate.
As adjuvant treatment in combination with tamoxifen or an aromatase inhibitor, of endocrine responsive early stage breast cancer in women at high risk of recurrence who are confirmed as pre-menopausal after completion of chemotherapy (see sections 4.3, 4.4, 4.8 and 5.1).
Molecule: triptorelin
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.